Alex T Müller
Alex T Müller
Bestätigte E-Mail-Adresse bei roche.com - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Generative Recurrent Networks for De Novo Drug Design
A Gupta, AT Müller, B Huisman, JA Fuchs, P Schneider, G Schneider
Molecular Informatics 36, 2017
2042017
Recurrent Neural Network Model for Constructive Peptide Design
AT Müller, JA Hiss, G Schneider
Journal of Chemical Information and Modeling, 2018
852018
modlAMP: Python for antimicrobial peptides
AT Müller, G Gabernet, JA Hiss, G Schneider
Bioinformatics 33 (17), 2753–2755, 2017
522017
Designing anticancer peptides by constructive machine learning
F Grisoni, CS Neuhaus, G Gabernet, AT Müller, JA Hiss, G Schneider
ChemMedChem 13 (13), 1300-1302, 2018
452018
Membranolytic anticancer peptides
G Gabernet, AT Müller, JA Hiss, G Schneider
MedChemComm 7 (12), 2232-2245, 2016
442016
Hybrid network model for “deep learning” of chemical data: application to antimicrobial peptides
P Schneider, AT Müller, G Gabernet, AL Button, G Posselt, S Wessler, ...
Molecular informatics 36 (1-2), 1600011, 2017
322017
Rational Design of Membrane‐Pore‐Forming Peptides
M Pillong, JA Hiss, P Schneider, YC Lin, G Posselt, B Pfeiffer, M Blatter, ...
Small 13 (40), 1701316, 2017
232017
In silico design and optimization of selective membranolytic anticancer peptides
GS G Gabernet, D Gautschi, AT Müller, CS Neuhaus, L Armbrecht, PS Dittrich ...
Scientific Reports, 2019
192019
Peptide–Membrane Interaction between Targeting and Lysis
K Stutz, AT Müller, JA Hiss, P Schneider, M Blatter, B Pfeiffer, G Posselt, ...
ACS Chemical Biology 12 (9), 2254-2259, 2017
112017
Sparse Neural Network Models of Antimicrobial Peptide‐Activity Relationships
AT Müller, AC Kaymaz, G Gabernet, G Posselt, S Wessler, JA Hiss, ...
Molecular Informatics 35 (11-12), 606-614, 2016
112016
De novo design of antimicrobial peptides: from sequence templates to artificial intelligence
AT Müller
PhD Thesis, 2018
12018
Morphing of Amphipathic Helices to Explore the Activity and Selectivity of Membranolytic Antimicrobial Peptides
AT Müller, G Posselt, G Gabernet, C Neuhaus, S Bachler, M Blatter, ...
Biochemistry, 2020
2020
COMPOUNDS FOR USE AS THERAPEUTICALLY ACTIVE SUBSTANCES IN THE TREATMENT OF RETINAL DISEASES
M Steger, A Mueller, B Fasching, D Mokady
US Patent US2,020,207,749, 2020
2020
COMPOUNDS FOR USE AS THERAPEUTICALLY ACTIVE SUBSTANCES IN THE TREATMENT OF RETINAL DISEASES
M Steger, A Mueller, B Fasching, D Mokady
US Patent US2,020,207,719, 2020
2020
COMPOUNDS FOR USE AS THERAPEUTICALLY ACTIVE SUBSTANCES IN THE TREATMENT AND/OR PREVENTION OF NEURORETINAL DISEASES
M Steger, A Mueller, M Marigo, B Fasching, D Mokady
WO Patent WO2,020,140,043, 2020
2020
N-(4-(OXAZOL-5-YL)PHENYL)CHROMANE-3-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS STIMULATORS OF THE PRODUCTION OF RETINAL PRECURSOR CELLS FOR THE TREATMENT OF NEURORETINAL …
M Steger, A Mueller, M Marigo, B Fasching, D Mokady
WO Patent WO2,020,140,050, 2020
2020
Interaction of Toxins and Peptides with Lipid Membranes Studied on a Microfluidic Device
S Bachler, P Drücker, AT Müller, C Del Don, EB Babiychuk, G Schneider, ...
Biophysical Journal 114 (3), 262a, 2018
2018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–17